Biosimilars Dodge Bullet As High Court Upholds ACA
Manufacturers of biologic drugs breathed a sigh of relief Thursday after the U.S. Supreme Court narrowly upheld the Obama administration's health reform law, which includes revolutionary changes to the industry's approval...To view the full article, register now.
Already a subscriber? Click here to view full article